Pages that link to "Q24317613"
Jump to navigation
Jump to search
The following pages link to The familial Parkinsonism gene LRRK2 regulates neurite process morphology (Q24317613):
Displaying 50 items.
- Leucine rich repeat kinase 2 (Q409961) (← links)
- Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism (Q21131229) (← links)
- Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. (Q21135493) (← links)
- GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1 (Q21144926) (← links)
- Parkinson's Disease: Genetics and Pathogenesis (Q22242000) (← links)
- LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool (Q24292798) (← links)
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice (Q24293070) (← links)
- Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP (Q24293723) (← links)
- Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease (Q24294458) (← links)
- LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress (Q24294466) (← links)
- MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2 (Q24294736) (← links)
- A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity (Q24296968) (← links)
- Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2) (Q24298459) (← links)
- LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex (Q24298891) (← links)
- Identification of potential protein interactors of Lrrk2 (Q24301415) (← links)
- LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth (Q24304347) (← links)
- ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2 (Q24305448) (← links)
- GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2 (Q24306167) (← links)
- LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study (Q24307455) (← links)
- A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation (Q24310126) (← links)
- Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily (Q24310218) (← links)
- Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment (Q24310262) (← links)
- RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk (Q24315688) (← links)
- An early endosome regulator, Rab5b, is an LRRK2 kinase substrate (Q24315778) (← links)
- Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation (Q24316270) (← links)
- LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of theDrosophilaNeuromuscular Junction (Q24316894) (← links)
- Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways (Q24316917) (← links)
- Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice (Q24317631) (← links)
- LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25 (Q24317760) (← links)
- Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies (Q24318474) (← links)
- The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro (Q24322792) (← links)
- The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration (Q24322927) (← links)
- The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation (Q24324345) (← links)
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease (Q24336432) (← links)
- LRRK2 regulates synaptic vesicle endocytosis (Q24336523) (← links)
- LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model (Q24338346) (← links)
- G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization (Q24339009) (← links)
- Regulation of the autophagy protein LC3 by phosphorylation (Q24627351) (← links)
- Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons (Q24628425) (← links)
- Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells (Q24651391) (← links)
- Intrabody and Parkinson's disease (Q24653530) (← links)
- LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model (Q24656256) (← links)
- Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models (Q24673667) (← links)
- In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells (Q26774092) (← links)
- Morphological changes of glutamatergic synapses in animal models of Parkinson's disease (Q26781619) (← links)
- Genetics of Parkinson's disease (Q26827825) (← links)
- The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease (Q26853537) (← links)
- LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson's Disease (Q26861279) (← links)
- Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic (Q27007413) (← links)
- Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications (Q27013695) (← links)